Literature DB >> 9008490

Proximal myotonic myopathy with MRI white matter abnormalities of the brain.

E Hund1, O Jansen, M C Koch, K Ricker, W Fogel, N Niedermaier, M Otto, E Kuhn, H M Meinck.   

Abstract

Proximal myotonic myopathy (PROMM) is an autosomal dominantly inherited multisystemic disorder characterized by myotonia, proximal muscle weakness, and cataracts. This disorder is not linked to the gene locus of myotonic dystrophy (DM). We describe three new families with PROMM. In all patients, CTG repeats of the DM gene in DNA from blood leukocytes were normal. MRI of the brain revealed a consistent pattern of marked white matter hyperintensity on T2-weighted images in four patients; two additional patients had similar but mild to moderate MRI abnormalities. The morphology of these abnormalities is unknown. Clinical symptoms of brain disease were not consistent and included mental changes with hypersomnia, parkinsonian features, stroke-like episodes, and seizures. The causative relationship of these clinical features with the MRI white matter abnormalities remains to be established. Our observations suggest that PROMM may involve the brain.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9008490     DOI: 10.1212/wnl.48.1.33

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  12 in total

1.  Proximal myopathy and diffuse white matter involvement in myotonic dystrophy type I.

Authors:  Kayihan Uluc; E Murat Arsava; Sevim Erdem; Ersin Tan
Journal:  J Neurol       Date:  2002-05       Impact factor: 4.849

Review 2.  Myotonic dystrophy type 2 and related myotonic disorders.

Authors:  Giovanni Meola; Richard T Moxley
Journal:  J Neurol       Date:  2004-10       Impact factor: 4.849

Review 3.  Genetics and molecular pathogenesis of the myotonic dystrophies.

Authors:  John W Day; Laura P W Ranum
Journal:  Curr Neurol Neurosci Rep       Date:  2005-02       Impact factor: 5.081

4.  Grey and white matter loss along cerebral midline structures in myotonic dystrophy type 2.

Authors:  Martina Minnerop; Eileen Luders; Karsten Specht; Jürgen Ruhlmann; Christiane Schneider-Gold; Rolf Schröder; Paul M Thompson; Arthur W Toga; Thomas Klockgether; Cornelia Kornblum
Journal:  J Neurol       Date:  2008-09-03       Impact factor: 4.849

Review 5.  Myotonic dystrophy: RNA pathogenesis comes into focus.

Authors:  Laura P W Ranum; John W Day
Journal:  Am J Hum Genet       Date:  2004-04-02       Impact factor: 11.025

6.  Brain involvement in myotonic dystrophies: neuroimaging and neuropsychological comparative study in DM1 and DM2.

Authors:  Vincenzo Romeo; E Pegoraro; C Ferrati; F Squarzanti; G Sorarù; A Palmieri; P Zucchetta; L Antunovic; E Bonifazi; G Novelli; C P Trevisan; M Ermani; R Manara; C Angelini
Journal:  J Neurol       Date:  2010-03-11       Impact factor: 4.849

7.  The brain in myotonic dystrophy 1 and 2: evidence for a predominant white matter disease.

Authors:  Martina Minnerop; Bernd Weber; Jan-Christoph Schoene-Bake; Sandra Roeske; Sandra Mirbach; Christian Anspach; Christiane Schneider-Gold; Regina C Betz; Christoph Helmstaedter; Marc Tittgemeyer; Thomas Klockgether; Cornelia Kornblum
Journal:  Brain       Date:  2011-11-29       Impact factor: 13.501

8.  Myotonic dystrophy type 1 presenting with stroke-like episodes: a case report.

Authors:  Jens D Rollnik; Ute Heinz; Olaf Lenz
Journal:  BMC Res Notes       Date:  2013-06-26

Review 9.  Brain pathology in myotonic dystrophy: when tauopathy meets spliceopathy and RNAopathy.

Authors:  Marie-Laure Caillet-Boudin; Francisco-Jose Fernandez-Gomez; Hélène Tran; Claire-Marie Dhaenens; Luc Buee; Nicolas Sergeant
Journal:  Front Mol Neurosci       Date:  2014-01-09       Impact factor: 5.639

Review 10.  Current Progress in CNS Imaging of Myotonic Dystrophy.

Authors:  Martina Minnerop; Carla Gliem; Cornelia Kornblum
Journal:  Front Neurol       Date:  2018-08-21       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.